Hypnotherapy for alopecia areata

P. Harrison,P. Štěpánek

DOI: https://doi.org/10.1111/j.1365-2133.1991.tb00644.x

IF: 11.113

1991-05-01

British Journal of Dermatology

Abstract:SIR, Interferons have been used in the treatment of viral papillomas, HIV-associated Kaposi's sarcoma, inflammatory dermatoses and cutaneous tumours.' We report a case of a Merkel cell tumour that was treated with interferon-a-2b (IFN). An 85-year-old man had a subcutaneous mass in his right leg excised in March 1987 and the histology and immunohistochemistry were typical for that of a Merkel cell tumour. Postoperatively he received radiotherapy, but the tumour recurred and in December 1987 a further excision was performed. The patient later returned in March 1988 with a recurrent mass that measured 3 x 3 cm and following excision, he had a course of superficial radiotherapy. There was a further recurrence along the excision margin in May 1988. He was then treated with IFN (Intron A) receiving 3 x lO*" U subcutaneously three times a week. The tumour became softer after 1 month and disappeared after 3 months. Subsequently there has been no recurrence with 1 year of follow up. Merkel cell tumour is a rare but aggressive form of skin cancer and there is a high rate of recurrence of 3 5-40% within a year of diagnosis.^'^ Locally recurrent lesions have been treated with variable success with further excision, amputation, radiation and chemotherapy.^'^ The advanced age and the poor health of many of the patients preclude the routine use of cytotoxic drug therapy. This case report suggests that IFN may produce a relatively long remission in the treatment of Merkel cell tumour.